A

Agios (AGIO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Agios (AGIO)

Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more

  • 29.00
  • 30.24
  • 28.69
  • 36.70
  • 0.2%
  • 10M
  • 660.16k
  • 460.60k
  • 1.6B
  • 16.75
  • -21.2%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.